1
©2013 MFMER | 3284068-1 ©2013 MFMER | 3284068-1
Comprehensive Echocardiographic Assessment of Adults with Congenital Heart Disease
Echocardiography of Complex Congenital Heart Disease
Naser M. Ammash, M.D., FACC
Frank Cetta, M.D., FACC, FASE
2
©2013 MFMER | 3284068-2
Disclosure Summary To CME Participants
As a provider accredited by ACCME, College of Medicine, Mayo Clinic (Mayo School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.
3
©2013 MFMER | 3284068-3
Disclosure Summary
Listed below are individuals with control of the content of this program who have disclosed
Relevant financial relationship(s) with industry
None
Listed below are individuals with control of the content of this program who have disclosed
No relevant financial relationship(s) with industry
Gina A. Anderson, B.A
Naser M. Ammash, M.D., FACC
Frank Cetta, M.D., FACC, FASE
I do intend to discuss off-label/investigative uses(s) of the following commercial products(s)/device(s):
None
4
©2013 MFMER | 3284068-4
Objectives
• Identify the hemodynamic issues that impact adults with various complex congenital heart diseases
• Review long-term outcome of various complex congenital heart diseases after surgical repair
• Report the impact of novel valve repair techniques for patients with complex congenital heart diseases
5
©2013 MFMER | 3284068-5
Distribution of Age at Death in Patients With Congenital Heart Disease in 1987-1988 and 2004-2005
051015202530
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85-89
≥90
Khairy et al: JACC 56:1149, 2010
Age at death (years)
Proportion of all deaths (%)
Year
1987-1988
6
©2013 MFMER | 3284068-6
Distribution of Age at Death in Patients With Congenital Heart Disease in 1987-1988 and 2004-2005
051015202530
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85-89
≥90
Khairy et al: JACC 56:1149, 2010
Age at death (years)
Proportion of all deaths (%)
Year
1987-1988
0 5 10 15 20 25 30
Year
2004-2005
7
©2013 MFMER | 3284068-7
Tetralogy of Fallot
8
©2013 MFMER | 3284068-8
Tetralogy of Fallot
Pink tetralogy Classic tetralogy Pulmonary atresia
9
©2013 MFMER | 3284068-9
Blalock-Taussig Shunt
Right common carotid artery
Right subclavian artery
Right pulmonary artery
Aorta
Pulmonary trunk
Brachiocephalic trunk (innominate artery)
10
©2013 MFMER | 3284068-10
Surgical Repair of TOF
Residua and sequelae are common
Late morbidity and mortality
11
©2013 MFMER | 3284068-11
26-Year-Old Repaired TOF in 1981 Dyspnea, MR Noted Pre-Partum Evaluation in 2005
29 mm mosaic porcine valve
12
©2013 MFMER | 3284068-12
26-Year-Old Repaired TOF in 1981 Dyspnea, MR Noted Pre-Partum Evaluation in 2005
13
©2013 MFMER | 3284068-13
26-Year-Old Repaired TOF in 1981 Dyspnea, MR Noted Pre-Partum Evaluation in 2005
14
©2013 MFMER | 3284068-14
Survival Without Reoperation Following TOF Repair Mayo Clinic 1955-1960, n=163
0
20
40
60
80
100
0 5 10 15 20 25 30
Murphy, 1993
Years
Su
rviv
al (%
)
88%
PR noted in 80% of patients
PR has detrimental long-term effect on RV size and function
PR is most common indication for re-operation
15
©2013 MFMER | 3284068-15
Pulmonary Regurgitation After TOR Repair Determinants
• Residual PV abnormality (bicuspid in 50%)
• Pulmonary valvotomy/valvectomy
• Extensive ventriculotomy/infundibulectomy
• Trans-annular patch repair
• Pulmonary annulus size
• Peripheral pulmonary artery stenosis
• Acquired CV/pulmonary diseases Pulmonary HTN
• Shunts, HTN, CAD, COPD/asthma, OSA
Ammash et al: CHD, 2007
16
©2013 MFMER | 3284068-16
Hemodynamic Substrate in for VT and SCD 465 Patients Following TOF Repair
Echo Within 12 Months
0
20
40
60
80
100
RVSP (>60 mm Hg) TR (≥ moderate) PR (≥ moderate)
Gatzoulis et al: Lancet 356:975, 2000
Patients
(%
)
VT
SD
AF
Arrhythmia-free
17
©2013 MFMER | 3284068-17
Pulmonary Regurgitation Severity Color Doppler
• Mild: PR noted in RVOT not PA
• Moderate: PR noted in the main PA
• Severe: PR noted in the branch PAs
18
©2013 MFMER | 3284068-18
Pulmonary Regurgitation Severity PW or CW Doppler
• Rapid decrease throughout diastole
• Return to baseline before end of diastole if low PA diastolic pressure
• High EDPR suggests pulmonary HTN
19
©2013 MFMER | 3284068-19
Pulmonary Regurgitation Severity PW or CW Doppler
20
©2013 MFMER | 3284068-20
Pulmonary Regurgitation Severity PR Index
Li et al: AHJ 147:165, 2004
PR index <0.77 identified severe PR
Predictive accuracy 95%
21
©2013 MFMER | 3284068-21
Pulmonary Regurgitation Severity Pressure Half Time
Silversides et al: JASE 16:1057, 2003
P ½t <100 msec identified severe PR:
Sensitivity 76%, specificity 94%
22
©2013 MFMER | 3284068-22
What to do?
When to intervene?
23
©2013 MFMER | 3284068-23
Pulmonary Regurgitation After TOF Repair
• PR tolerant for many years – subtle on PR
• Lack of symptoms doesn’t reflect RV dysfunction
• Degree of adaption
• Long standing PR
• ↑ RVEDV
• TV annular dilation
• TV regurgitation
• ↓ RV dysfunction
• ↓ FAC
24
©2013 MFMER | 3284068-24
Optimal Timing of Intervention in PR
0
20
40
60
80
100
0 10 20
Years
Surv
ival
Severe PR RV enlargement
RV dysfunction
Symptoms
Time ?
25
©2013 MFMER | 3284068-25
Pulmonary Regurgitation After TOF Repair Indications for Intervention
• Symptoms, decline in exercise capacity
• Moderate-Severe or progressive RVE or dysfunction
• Symptomatic or sustained atrial arrhythmias
• Spontaneous VT or inducible VT
• QRS prolongation (>180 msec)
• LV dysfunction (usually after RV dysfunction)
• RVOT obstruction: MIG >50 mm Hg or RVSP 70% systole
• Residual shunt, significant TR
• Early LV dysfunction Ammash et al: CHD, 2007
26
©2013 MFMER | 3284068-26
TOF repair
RVOT complications
Arrhythmias
Residual VSD
AV and TV regurgiation
RV, LV dysfunction
Pulmonary hypertension
Endocarditis
27
©2013 MFMER | 3284068-27
Echo Examination Post TOF Repair Comprehensive
• Level and severity of pulmonary stenosis
• Severity of pulmonary and TV regurgitation
• RV and PA systolic pressures
• RV size and function
• Residual atrial or ventricular septal defect
• LV size and function
• Ascending aorta dilation/AR
28
©2013 MFMER | 3284068-28
RV Dysfunction After TOF Repair Visual Estimate
29
©2013 MFMER | 3284068-29
Selected Indices of RV Contractility Functional parameters Normal value Load dependence
RVEF (%) 61±7 (45-76)
>40-45 +++
RVFAC (%) >32 +++
TAPSE (mm ) >15 +++
Small annular (cm/s) >12 +++
Strain
Basal: 19±6
Mid: 27±6
Apical: 32±6
+++
Strain rate (s-1)
Basal: 1.50±0.41
Mid: 1.72±0.27
Apical: 2.04±0.41
++
RVMPI 0.28±0.04 ++
dP/dt max (mm Hg/s) 100-250 ++
30
©2013 MFMER | 3284068-30
PR Post TOF Repair MRI
Normal RVEDV ≤115 mL/m2
Normal RVESV ≤47 mL/m2
31
©2013 MFMER | 3284068-31
RVEDV Before and After PVR in TOF MRI Study in 17 Patients
• Presence of either
• RVEDV >170 cc/m2 or
• RVESV >85 cc/m2
Therrien: AJC, 2005
No normalization
of RV volumes
150 < RVEDV <170
RV volume ↓ a mean of 28% RVEF does not change Oosterhof: Circ 116, 2007
32
©2013 MFMER | 3284068-32
RV Dysfunction After TOF Repair Diastolic Dysfunction
33
©2013 MFMER | 3284068-33
RV Dysfunction After TOF Repair Diastolic Dysfunction
34
©2013 MFMER | 3284068-34
43-Year-Old Lady Status-Post TOF Repair at Age 14 VT Status-Post RFA 8 Years Ago, Now DOE
RVSP = 56 + 10
= 66 mmHg
35
©2013 MFMER | 3284068-35
44-Year-Old Repaired TOF With Dyspnea
36
©2013 MFMER | 3284068-36
44-Year-Old Repaired TOF With Dypnea
PASP = 66 – Peak PV grad
= 66 – 10 = 56 mm Hg
37
©2013 MFMER | 3284068-37
Pulmonary HTN in r-TOF
• Prior systemic to pulmonary shunt
• Distal pulmonary stenosis
• Residual shunt
• LV dysfunction (systolic, diastolic)
• Associated MV disease
• Sleep apnea
• Chronic lung disease
38
©2013 MFMER | 3284068-38
43-Year-Old Lady Status-Post TOP Repair at Age 14 VT Status-Post RFA 8 Years Ago, Now DOE
Moderate – Severe left PS from prior Lt BT
39
©2013 MFMER | 3284068-39
43-Year-Old Lady Status-Post TOP Repair at Age 14
Hybrid repair: Lt PA stent + Pulmonary Valve Replacement
40
©2013 MFMER | 3284068-40
Pulmonary Regurgitation After TOF Repair
• Important determinant of morbidity/mortality
• Dyspnea, RVE/D, arrhythmia, LVD, SCD
• Modified approach of repairing TOF
• Early identification/evaluation by expert
• Timing of intervention can be challenging
• PR assessment is only 1 component of comprehensive Echo examination
41
©2013 MFMER | 3284068-41
Tetralogy of Fallot Anomalous CA
Anomalous CAD in 3-7%
LAD from RCA in TOF
42
©2013 MFMER | 3284068-42
Pulmonary Regurgitation After TOF Repair Valve Replacement Options
Heterograft
Percutaneous
Homograft
Mechanical
43
©2013 MFMER | 3284068-43
Melody Valve
• Bovine jugular venous valve segment
• Platinum-iridium stent
44
©2013 MFMER | 3284068-44
Indications Melody Valve FDA Approved Under HDE – 2010
• Circumference RVOT conduit with ≥16 mm diameter at time of original implantation
• Inner diameter ≤22 mm
• Regurgitation and/or stenosis
• ≥ moderate PR
• RVOT mean gradient ≥35-40 mm Hg
45
©2013 MFMER | 3284068-45
Post-Implant Intracardiac Echo
Extending the “lifespan” of RV to PA conduits
46
©2013 MFMER | 3284068-46
Safety Considerations
Procedural Risks
• Coronary artery compression
• Conduit rupture
• Device embolization
Device Risks
• Stent fracture
• Pulmonary emboli
• Endocarditis
47
©2013 MFMER | 3284068-47
Single Ventricle Univentricular Hearts
Double inlet Single inlet Common inlet
Mitral valve atresia
Hypoplastic LHS
Hypoplatic RHS
Pulmonary atresia/IVS
Heterotaxia
48
©2013 MFMER | 3284068-48
24-Year-Old Tricuspid Atresia
49
©2013 MFMER | 3284068-49
31-Year-Old Astronomer With DILV
50
©2013 MFMER | 3284068-50
Single Ventricle Adult Presentation
• Non-operated
• Unobstructed pulmonary circulation
• Eisenmenger syndrome
• Pulmonary stenosis (at or below PV)
• Balanced circulation with cyanosis
• Normal pulmonary pressure
• Palliated if normal PAP and ventricular fracture
• Systemic to pulmonary shunt
• Fontan operation
51
©2013 MFMER | 3284068-51
Single Ventricle Adult Presentation
• Non-operated
• Unobstructed pulmonary circulation
• Eisenmenger syndrome
• Pulmonary stenosis (at or below PV)
• Balanced circulation with cyanosis
• Normal pulmonary pressure
• Palliated if normal PAP and ventricular fracture
• Systemic to pulmonary shunt
• Fontan operation
52
©2013 MFMER | 3284068-52
31-Year-Old Astronomer With DILV
53
©2013 MFMER | 3284068-53
Eisenmenger Syndrome
54
©2013 MFMER | 3284068-54
VSD Eisenmenger
55
©2013 MFMER | 3284068-55
Eisenmenger
Cardiovascular
Glomerular sclerosis
Infection
Gall stones
Pulmonary
Hypertrophic osteoarthopathy
Neurologic
Hematologic
56
©2013 MFMER | 3284068-56
Syndrome in Eisenmenger Syndrome
0
20
40
60
80
100
0 2 4 6 8 10 12 14
Diller et al: EHJ 27:1737, 2006
Age (years)
Su
rviv
al (%
)
171 patients Age 32±12 years
Eisenmenger patient P=0.02
Predicted survival
Simple lesion Complex
lesion
57
©2013 MFMER | 3284068-57
Single Ventricle Adult Presentation
• Non-operated
• Unobstructed pulmonary circulation
• Eisenmenger syndrome
• Pulmonary stenosis (at or below PV)
• Balanced circulation with cyanosis
• Normal pulmonary pressure
• Palliated if normal PAP and ventricular fracture
• Systemic to pulmonary shunt
• Fontan operation
58
©2013 MFMER | 3284068-58
26-Year-Old With DILV and Sub PS
59
©2013 MFMER | 3284068-59
26-Year-Old With DILV and Sub PS
60
©2013 MFMER | 3284068-60
Single Ventricle Adult Presentation
• Non-operated
• Unobstructed pulmonary circulation
• Eisenmenger syndrome
• Pulmonary stenosis (at or below PV)
• Balanced circulation with cyanosis
• Normal pulmonary pressure
• Palliated if normal PAP and ventricular fracture
• Systemic to pulmonary shunt
• Fontan operation
61
©2013 MFMER | 3284068-61
Blalock-Taussig Shunt
Right common carotid artery
Right subclavian artery
Right pulmonary artery
Aorta
Pulmonary trunk
Brachiocephalic trunk (innominate artery)
62
©2013 MFMER | 3284068-62
Single Ventricle
• Glenn anastomosis: SVC to right PA
Classic bi-directional
Normal LVEF
LVEDP <12 mm Hg
TPG <10 mm Hg
MPAP <14-18 mm Hg
63
©2013 MFMER | 3284068-63
Glenn Anastomosis Isolated or TCP Connection
• Suprasternal short axis view
• Use low Nyquist limit and filter
• Low velocity biphasic forward flow
• Laminar color flow
64
©2013 MFMER | 3284068-64
Glenn Anastomosis Isolated or TCP Connection
Need to exclude obstruction by color/spectral
If high velocity or Mosaic color Doppler
65
©2013 MFMER | 3284068-65
Fontan Operation
• Fontan is not a specific procedure, but rather a concept
• Diverting all systemic venous return into the pulmonary artery bypassing RV
• Combination of different surgeries
• Palliation for the functionally Univentricular heart or ‘single’ ventricle
66
©2013 MFMER | 3284068-66
Unique Fontan Physiology
• Pulmonary flow does not have a ventricular pump
• Systemic ventricular function provides energy for transpulmonary flow
• Intrathoracic pressure changes also help
• Positive pressure ventilation poorly tolerated
• Pulmonary arterial flow obstructions will behave like venous stenosis
• Even small gradients can be bad
67
©2013 MFMER | 3284068-67
Optimal Candidates for Fontan Revised Criteria
1. Normal PA size and distribution
2. Low mean PA pressure <15 mm Hg
3. Normal pulmonary vascular resistance
4. Normal LV systolic and diastolic function
5. ± no AV valve regurgitation
Optimal results in those with optimum selection Any deviation can result in Fontan failure
Allow smooth stream-lined BF from veins to lungs
68
©2013 MFMER | 3284068-68
Echocardiographic Essentials Comprehensive Assessment
1. Fontan pathway
2. Ventricular size and function
3. Atrioventricular valve
4. Ventriculoarterial connection
5. Pulmonary veins and ASD
6. Right Atrium
7. Hepatic veins and inferior vena cava
8. Ascites and pleural effusion
69
©2013 MFMER | 3284068-69
Fontan Operation Historical Perspective
Kreutzer, 1973 Fontan, 1971
70
©2013 MFMER | 3284068-70
Fontan Operation Modifications
71
©2013 MFMER | 3284068-71
Fontan Operation Modifications
72
©2013 MFMER | 3284068-72
Post-Fontan Examination
• Acyanotic unless residual shunt
• Normal JVP except
• Fontan obstruction/failure
• Atrial arrhythmia, flutter waves ?
• Single S2 (palpable A2 if anterior aorta)
• No murmur except
• AVV regurgitation or sub AS
• Right sided CHF if complicated
73
©2013 MFMER | 3284068-73
Fontan
Fontan obstruction
Cyanosis
Ventricular dysfunction
Liver cirrhosis
Protein losing enteropathy
RA thrombi embolism
Arrhythmia
Pul V Obst; Sub AS; Co A
AV valve regurgitation
74
©2013 MFMER | 3284068-74
Echocardiographic Essentials Comprehensive Assessment
1. Fontan pathway
2. Ventricular size and function
3. Atrioventricular valve
4. Ventriculoarterial connection
5. Pulmonary veins and ASD
6. Right Atrium
7. Hepatic veins and inferior vena cava
8. Ascites and pleural effusion
75
©2013 MFMER | 3284068-75
Echocardiographic Essentials Fontan Pathway
• Rely on surgical record to identify type of connection
• Cavopulmonary anastomosis: Classic Glenn
• Bidirectional cavopulmonary connection
• Atriopulmonary connection
• Extracardiac or intracardiac conduit from IVC to main or right PA with bidirectional cavopulmonary connection
• Intracardiac tunnel from IVC to right PA with bidirectional cavopulmonary connection
Challenging anatomic and surgical variations
Use all windows in Fontan assessment
76
©2013 MFMER | 3284068-76
24-Year-Old SV With RAA to RVOT Fontan
77
©2013 MFMER | 3284068-77
24-Year-Old SV With RAA to RVOT
Pulsatile Fontan flow
Peaks in late systole and diastole
Both increase with inspiration
78
©2013 MFMER | 3284068-78
RA Appendage to PA Connection
• Horizontal plane
• Modified parasternal short axis
• Subcostal window
79
©2013 MFMER | 3284068-79
RA Appendage to PA Connection
80
©2013 MFMER | 3284068-80
25-Year-Old With PA/IVS, Status-Post Fontan Intracardiac Conduit
81
©2013 MFMER | 3284068-81
25-Year-Old With PA/IVS, Status-Post Fontan Intracardiac Conduit
82
©2013 MFMER | 3284068-82
Lateral Tunnel Fontan
LV
Lateral Right
Atrial Tunnel
LA
83
©2013 MFMER | 3284068-83
21-Year-Old With TA, Status-Post Fontan Lateral Tunnel
LV
Lateral Right
Atrial Tunnel
LA
84
©2013 MFMER | 3284068-84
Tricuspid Atresia, Normally Related GA Extracardiac Fontan
85
©2013 MFMER | 3284068-85
Tricuspid Atresia, Normally Related GA Extracardiac Fontan
86
©2013 MFMER | 3284068-86
‘Fenestrated’ Fontan
• Purposeful placement of small (3-4 mm) ASD
• Provides constant preload to ventricle
• Decreases in systemic venous pressure (pop off)
• Causes mild cyanosis (R to L shunt)
• Potential for paradoxical embolism
• Echo assessment
• Presence of gradient through
• AP4C, subcoastal
• Location and size
• Agitated saline (optional)
87
©2013 MFMER | 3284068-87
Fenestration Physiology
• Any ASD in Fontan will always show R L shunt
• Mean RAP is always > LAP
• Mean gradient of fenestration flow reflects trans-pulmonary gradient (5-8 mm Hg)
Any TPG of >8 mm Hg requires an explanation
88
©2013 MFMER | 3284068-88
Echocardiographic Essentials Ventricular Size and Function
• Systolic function
• 2D qualitative assessment of volume and global function evaluation
• Diastolic function
• AV valve, annulus and pulmonary veins
• Spectral and tissue Doppler
Echocardiographic Option
Myocardial performance index
Systolic rates of ventricular pressure change (Dp/Dt)
Fractional area shortening
Annular systolic DTI EF with 2D or 3D imaging
89
©2013 MFMER | 3284068-89
Echocardiographic Essentials
• Pulmonary veins
• 2D assessment with color and spectral Doppler
• Assess for obstruction of right pulmonary veins
• Best views: AP4C, subcoastal
• AV valve connection
• 2D and Doppler assessment of AV valve regurgitation presence and severity (PLAX, PSAX, AP4C)
• PISA assessment of RV/ERO, vena contracta
• Systolic flow reversal in pulmonary veins
90
©2013 MFMER | 3284068-90
11-Year-Old: TA, TGA, Sub AS and Coarction Fontan at Age 4, Sub AS x2, AVR
RPA
RA
LPA
Fontan
91
©2013 MFMER | 3284068-91
11-Year-Old: TA, TGA, Sub AS and Coarction Fontan at Age 4, Sub AS x2, AVR
Fontan conversion to intra-atrial conduit
Cryoablation for atrial flutter
R P vein
RA L P vein
LA
92
©2013 MFMER | 3284068-92
23-Year-Old With CHF
• Hypoplastic right HS
• TV hypoplasia, near pulmonary atresia
• Right BT at 3 days old
• Pulmonary vavlotomy at 2 years old
• Modified Fontan at 15 years old (RA to right PA)
• Edema, ascites, DOE in August 2007
• Atrial fibrillation
• New loud systolic murmur
93
©2013 MFMER | 3284068-93
23-Year-Old With CHF and PLE
1. Conversion to IA conduit BDCPA
2. Patch closure of TV
3. Lt AVV annuloplasty ring
4. Bi-atrial maze
5. Fenestration in atrial septum
1AT: 304 to 27 mg/dL
T. protein: 5.5 to 6.5 g/dL
Albumin: 3-3 to 6 g/dL
94
©2013 MFMER | 3284068-94
35-Year-Old With Tricuspid Atresia Fontan RAA to PA With PLA
Not suitable for Fontan conversion
LVEDP 16 mm Hg, MR, Cr = 2.8
95
©2013 MFMER | 3284068-95
35-Year-Old With Tricuspid Atresia RAA to PA Fontan
96
©2013 MFMER | 3284068-96
Echocardiographic Essentials Comprehensive Assessment
1. Fontan pathway
2. Ventricular size and function
3. Atrioventricular valve
4. Ventriculoarterial connection
5. Pulmonary veins and ASD
6. Right Atrium
7. Hepatic veins and inferior vena cava
8. Ascites and pleural effusion
97
©2013 MFMER | 3284068-97
Indications for TEE in Fontan
• Atrial arrhythmia necessitating cardioversion
• Severe spontaneous Echo contrast
• Systemic/pulmonary embolization
• Unexplained cyanosis
• Uncertainty about ventricular function or AV valve regurgitation
• Uncertainty about pulmonary venous obstruction
98
©2013 MFMER | 3284068-98
Adult Complex CHD Survivor
• No longer rare or odd
• Natural survivors
• Post-repair
• Challenging problems
• Repair or palliation
• Residua and sequelae
• Many need re-intervention
• Require specialized lifelong care
99
©2013 MFMER | 3284068-99
Wilhelm Ebstein
1836-1912
100
©2013 MFMER | 3284068-100
Ebstein Anomaly
• June 28, 1864
• 19-year-old laborer admitted to Allerheiligen Hospital in Breslau with shortness of breath and palpitations
• Died on July 6th
• Ebstein performed an autopsy the next day
Ebstein: Arch Anat Physiol 238, 1866
101
©2013 MFMER | 3284068-101
102
©2013 MFMER | 3284068-102
Thin, Translucent, Redundant, Sail-like Anterior Leaflet
Courtesy: William Edwards Collection
Anterior TV leaflet in Ebstein
103
©2013 MFMER | 3284068-103
Normal Delamination (Separation) of TV from RV Myocardium
RA
RV
EC
RCA RA
RV
EC
TV
104
©2013 MFMER | 3284068-104
Failed TV Delamination in Ebstein Anomaly
RA
RV
RA
RV
Atrialized
RV
105
©2013 MFMER | 3284068-105
Ebstein Anomaly Genetics
• 1/210,000 live births
• MYH7 mutation + LVNC
• NKX 2.5 mutation
106
©2013 MFMER | 3284068-106
Ebstein Presentation Varies
• Asymptomatic
• Cyanosis (ASD/PFO = 30-78%)
• Arrhythmia (WPW = 15%)
• Dyspnea on exertion
• Edema
• Cardiomegaly
• Intrauterine death
107
©2013 MFMER | 3284068-107
Clinical Evaluation Pearls
• 60% diagnosed age <1 year
• 38% cyanotic
• 66% of neonates & infants
• 10% diagnosed prenatally
• Murmur most common in older children
• JVP frequently normal
• 10% not diagnosed until adulthood
108
©2013 MFMER | 3284068-108
Spectrum of Presentation
Severe Mild
109
©2013 MFMER | 3284068-109
The Child With This CXR…
110
©2013 MFMER | 3284068-110
… Had This Echo
111
©2013 MFMER | 3284068-111
Typical Ebstein ECG
Courtesy: Bryan Cannon, M.D.
Prolonged PR interval, marked RBBB, very large P waves
112
©2013 MFMER | 3284068-112
Atypical Ebstein ECG Normal PR, No RBBB Accessory Pathway
Courtesy: Bryan Cannon, M.D.
113
©2013 MFMER | 3284068-113
Approach to Patient With Ebstein & WPW
• 15% of patients with Ebstein anomaly
• Usually right-sided pathway
• RBBB + right-sided accessory path = synchronous RV/LV contraction narrow QRS
• EPS/RFA prior to OR for TV repair
• Long-term surveillance, high recurrence of atrial arrhythmia
114
©2013 MFMER | 3284068-114
Failed Delamination Results in
• Adherence of leaflets to underlying RV myocardium
• Displacement of the anular hinge points
115
©2013 MFMER | 3284068-115
Displacement septal
(8 mm/m2) and posterior
Dilated TVA
Dilated RA
Enlarged
atrialized RV
Small
functional RV
116
©2013 MFMER | 3284068-116
Apical Displacement Index Normal <8 mm/m2 Ebstein Anomaly
RA
RV
LV
23 mm/1.5 m2 = 15.3 mm/m2
117
©2013 MFMER | 3284068-117
Spiral Displacement of TV Anterior/Apical Rotation of Functional Orifice
Modified from Schrieber C Anderson: J Thorac Cardiovasc Surg, 1999
118
©2013 MFMER | 3284068-118
Ebstein Anomaly
• Spectrum of abnormalities of TV leaflets and RV myocardium
• Abnormalities of all leaflets
• Anterior, inferior, septal leaflets
• Delamination issues
• Inferior displacement and anterior/apical rotation of the septal leaflet
• More than valve problem, but rather a cardiomyopathy
119
©2013 MFMER | 3284068-119
Repairs for Ebstein Anomaly
• Danielson
• da Silva
• Ross
• Hardy
• Carpentier
• Quaegebeur
• Schmid
• Vargas
• Starnes
• Hetzer
• Meisner
• Sebening
• Kaushal
• Knott-Craig
• Friesen
• Chauvaud
• Ullmann
• Kaneko
• Wu
• Sano
120
©2013 MFMER | 3284068-120
Gordon K. Danielson Joseph A Dearani
121
©2013 MFMER | 3284068-121
Ebstein Anomaly Indications for Operation
• exercise tolerance, cyanosis
• Progressive RV dilation
• Before significant RV dysfunction
• Onset, progression of atrial arrhythmias
• Earlier operation if TV repair is likely
• Prior to LV dysfunction
122
©2013 MFMER | 3284068-122
Danielson Repair 1974
123
©2013 MFMER | 3284068-123
Pre-Cone Era
124
©2013 MFMER | 3284068-124
Overall Survival
0
20
40
60
80
100
0 5 10 15 20
Years
Surv
ival (%
)
539 332 200 121 54
10 year = 84.7%
20 year = 71.2%
125
©2013 MFMER | 3284068-125
Multivariate Predictors of Overall Mortality
HR P
Mild mitral regurgitation 6.84 0.01
Mild PS 3.20 0.01
Moderate ↓ RV function 2.76 0.01
Accessory tract ablation 0.20 0.01
126
©2013 MFMER | 3284068-126
Late Survival Free of Reoperation
0
20
40
60
80
100
0 5 10 15 20
Years
Late
surv
iva
l fr
ee o
f
reopera
tion (
%)
506 307 166 91 37
10 year = 74.1%
20 year = 46.1%
127
©2013 MFMER | 3284068-127
Late Functional Status
NYHA class I or II 83%
NYHA class III or IV 16%
128
©2013 MFMER | 3284068-128
• RV dysfunction
• Mitral and RVOTO surgery
• Correlation with ↑ early mortality
LV dysfunction correlated with ↑ late mortality
Early referral
129
©2013 MFMER | 3284068-129
Anatomic Tricuspid Valve Repair
130
©2013 MFMER | 3284068-130
Surgical Delamination
Dearani et al, 2008
AL
IL
SL
131
©2013 MFMER | 3284068-131
Cone Repair for Ebstein Anomaly
132
©2013 MFMER | 3284068-132
Cone Technique Repair at True Anatomic Annulus via Surgical Leaflet Delamination
Preop Postop
133
©2013 MFMER | 3284068-133
134
©2013 MFMER | 3284068-134
135
©2013 MFMER | 3284068-135
136
©2013 MFMER | 3284068-136
137
©2013 MFMER | 3284068-137
138
©2013 MFMER | 3284068-138
Cone Repair
Preop Postop
139
©2013 MFMER | 3284068-139
Tricuspid Valve Repair in Pediatric Patients With Ebstein Anomaly
The Mayo Clinic Experience in the Current Era
140
©2013 MFMER | 3284068-140
Mayo Clinic Cone Repair <21-Years-Old June 2007-December 2012
88
Excluded n=4 Cone repair attempted
n=84
Early reop n=3
Early death n=1
(19 d, ECMO) Cone success
n=80
Valve replaced n=1
Re-repair n=2
141
©2013 MFMER | 3284068-141
Mayo Clinic Cone Repair <21-years-old June 2007-December 2012
82/84 (98%) repaired by time of hospital discharge
142
©2013 MFMER | 3284068-142
Additional Surgical Procedures
ASD/PFO closure 70%
Surgical Maze 33%
Bidirectional Glenn 31%*
*3 prior
143
©2013 MFMER | 3284068-143
Cone Repair Outcomes
Early mortality 1/84 (1.2%)
Early reoperation for TV
(prior to hospital discharge)
3/83 (3.6%)
2 re-repair
1 replaced
Late mortality (MVA) 1/82 (1.2%)
Late re-re-repair 1/81 (1.2%)
144
©2013 MFMER | 3284068-144
Cone Repair Early Breakdowns
• Age, gender not associated with early Cone failure
• Muscularization of anterior leaflet and absence of septal leaflet – factors that may preclude Cone repair
• Steep learning curve
No early Cone
breakdowns since 2010
145
©2013 MFMER | 3284068-145
Echo Follow-Up Data
Follow-up data available 94%
Time from hospital discharge 0.8±0.2 years
(0-5.5 years)
Tricuspid stenosis (>5 mm Hg) 6/81 (7.4%)
Grade of TR on last Echo
None/mild TR* 83%
Moderate 13%
Severe 4% *Annuloplasty ring use associated with less short-term TR (P=0.01)
146
©2013 MFMER | 3284068-146
Conclusions/Speculations Ebstein Anomaly 2013
• 98% successful Cone repair in young
• Intervene prior to RV dysfunction
• Selective use of 1.5 ventricle strategy
• Cone anatomic repair for most valve morphologies
• Durable repair in short term follow-up
• Replacement still important in older adult +/- Maze
• Long-term surveillance of RV and TV
147
©2013 MFMER | 3284068-147
Complete TGA After Surgical Correction
Management After Atrial and Arterial Switch Operations
148
©2013 MFMER | 3284068-148
d-TGA
A Brief Review
149
©2013 MFMER | 3284068-149
Complete-TGA
Ao PA
LV RV
150
©2013 MFMER | 3284068-150
• Complete TGA or (d-TGA)
• Atrial switch for TGA
• Mustard and Senning
• Arterial switch for TGA
• Jatene with LeCompte
• Rastelli for TGA + PS + VSD
• Congenitally-corrected TGA (L-TGA)
151
©2013 MFMER | 3284068-151
All patients should be seen periodically in a
center where expertise in the clinical evaluation,
imaging and hemodynamic assessment of adult
congenital heart disease is available
152
©2013 MFMER | 3284068-152
Complete-TGA Mustard Operation
153
©2013 MFMER | 3284068-153
Atrial Switch Operations Mustard or Senning
• 20-year-old survival = 80%
• Successful pregnancies
• Late attrition from
• RV failure
• Arrhythmia
• Reduced exercise capacity
• 61% late gadolinium enhancement (fibrosis)
Wilson et al: JACC, 1998
PV
LV
IVC
RV
154
©2013 MFMER | 3284068-154
Complete-TGA Status-Post Mustard
155
©2013 MFMER | 3284068-155
Complete-TGA Status-Post Senning
156
©2013 MFMER | 3284068-156
Complete-TGA Imaging After Mustard/Senning
*Parasternal long-axis image demonstrating the superior vena cava portion of systemic venous baffle as it enters left atrium; portion of PV is also visualized in this image
157
©2013 MFMER | 3284068-157
Complete-TGA Imaging After Mustard/Senning
Apical 4-chamber 2-D and color Doppler assessment of patient after Senning operation with significant PV pathway obstruction (arrow); proximal SV is also visualized in this image
158
©2013 MFMER | 3284068-158
Complete-TGA Imaging After Mustard/Senning Echocardiography in Pediatric and Adult Congenital Heart Disease
IVC after atrial switch procedure in d-TGA
Tilting into true apical 4-chamber view from more posterior PV pathway Left: IVC
3-D images from apical 4-chamber projection *Left atrium #Right atrium
* * #
#
IVC
LV
PV
LV
159
©2013 MFMER | 3284068-159
Evaluation of Adult With Transposition After Atrial Switch Operation
Stent placement after Mustard operation with history of IVC baffle obstruction
Stent
Stent
Stent
160
©2013 MFMER | 3284068-160
Long-Term Outcome After Mustard
• 45 patient cohort assessment in 1997
• Follow-up decade later
• Mean age: 25 years (19-37)
• Time from Mustard: 24 years (18-33)
• 87% alive without transplant
• 54% persistent rhythm abnormality
• 26% pacemaker
Ebenroth & Hurwitz: Congenit Heart Dis, 2007
161
©2013 MFMER | 3284068-161
Issues After Atrial Switch Mustard or Senning
• Rhythm problems
• 40% NSR at 20 years post-op
• Fate of the systemic RV
• Progressive TR
• RV systolic dysfunction
• Venous baffle obstruction
• Mustard: SVC > IVC
• Senning: Pulmonary veins > systemic veins
162
©2013 MFMER | 3284068-162
Complete-TGA Status-Post Mustard Operation
163
©2013 MFMER | 3284068-163
Complete-TGA Status-Post Mustard Operation
164
©2013 MFMER | 3284068-164
Complete-TGA Status-Post Mustard Operation
165
©2013 MFMER | 3284068-165
Complete-TGA Status-Post Mustard Operation
166
©2013 MFMER | 3284068-166
Complete-TGA Status-Post Mustard Operation
167
©2013 MFMER | 3284068-167
Systemic RV Dysfunction
“The management is the same as LV dysfunction in a ‘normal’ heart”
• Beta-blockade
• Usually avoid
• Patients prone to bradyarrhythmia
• Afterload reduction ?
168
©2013 MFMER | 3284068-168
Systemic RV Dysfunction ACE Inhibition in Complete TGA
• 14 patients status-post Mustard
• Enalapril >6 months
• No improvement
• Exercise tolerance
• Hemodynamics
• Remodeling
• 9 (64%) increased their VO2max by 27%
0
5
10
15
20
25
30
35
Before ACEinhibitors
After ACEinhibitors
Hechter et al: Am J Cardiol, 2001
VO
2m
ax (
mm
Hg
-1 m
in-1
)
169
©2013 MFMER | 3284068-169
Systemic RV Dysfunction Limited Data
• Dore et al: Circulation, 2004
• Losarten vs placebo trial (n=29)
• No improvement in exercise capacity or reduction in NT-proBNP levels
• Giardini et al: Int J Cardiol, 2006
• Carvedilol in systemic RV (n=8)
• Safe and + RV modeling
• Severe case reports of CRT in systemic RV
• Shortening of the QRS
• Symptom improvement of CHF
170
©2013 MFMER | 3284068-170
Contraction of Systemic RV
• Normal RV free wall shortening
• Longitudinal > Circumferential
• Systemic RV (n=14) status-post Senning
• Circumferential > Longitudinal
• Adaptive effect, but no torsion ?
Pettersen et al: JACC, 2007
171
©2013 MFMER | 3284068-171
Assessing Function of Systemic RV RV Strain in Normal RV and LV and in Patients With d-TGA
Helle-Valle et al: J Am Coll Cardiol 49:2450, 2007
Normal RV Systemic RV Normal LV
200 ms
Longitudinal
strain (%)
Circumferential
strain (%)
ECG
0
-15
-30
0
-15
-30
172
©2013 MFMER | 3284068-172
Atrial Switch Operations MRI Evaluation
• 61% late gadolinium enhancement (fibrosis)
• Correlated with age
• Inversely with RVEF
• 44% of these with full-thickness anterior free wall involvement
Royal Brompton Group: Circulation, 2005
173
©2013 MFMER | 3284068-173
Case
28-year-old with TGA
Status-Post Senning
174
©2013 MFMER | 3284068-174
Please submit movie file:
4senningPVobs.mpg
175
©2013 MFMER | 3284068-175
Please submit movie file:
4senningPVobscolor.mpg
176
©2013 MFMER | 3284068-176
Pulmonary vein baffle mean gradient = 14 mm Hg
177
©2013 MFMER | 3284068-177
178
©2013 MFMER | 3284068-178
Intra-op TEE
Please submit movie file:
prestnet.mpg
179
©2013 MFMER | 3284068-179
Mean Gradient = 12 mm Hg
180
©2013 MFMER | 3284068-180
Hybrid Procedure
Please submit movie file:
wire.mpg
181
©2013 MFMER | 3284068-181
Please submit movie file:
4senningPVobscolor.mpg
Please submit movie file:
stentdeploy.mpg
182
©2013 MFMER | 3284068-182
Please submit movie file:
postcolor.mpg
183
©2013 MFMER | 3284068-183
Post-Stent Gradient = 4 mm Hg
184
©2013 MFMER | 3284068-184
5 Months Later
185
©2013 MFMER | 3284068-185
5 Months Later
Please submit movie file:
fusenningPVstentcolor.mpg
186
©2013 MFMER | 3284068-186
Re-Intervention After Mustard or Senning
• Pacemaker
• Tricuspid valve repair/replace – rarely
• Venous baffle stent placement
• Late arterial switch – rare
• Cardiac transplantation
• But not too soon
187
©2013 MFMER | 3284068-187
Transposition of Great Arteries Complete-TGA
Arterial Switch
188
©2013 MFMER | 3284068-188
Status-Post Arterial Switch (ASO)
189
©2013 MFMER | 3284068-189
Issues After Arterial Switch
• Early
• Coronary insufficiency
• PA stenosis after LeCompte
• Late
• Progressive aortic regurgitation
• Generally
• Few long-term rhythm or ventricular function issues
190
©2013 MFMER | 3284068-190
191
©2013 MFMER | 3284068-191
AR After ASO
• 15% at 6 years post
• 30% at 15 years post
• Only 1.4% required reoperation
• Increased with
• VSD
• Older age at ASO
• Prior PA band
• PA – aorta size mismatch
192
©2013 MFMER | 3284068-192
Rastelli Operation TGA + VSD + PS
Giancarlo Rastelli
1933-1970
193
©2013 MFMER | 3284068-193
Rastelli Operation TGA + VSD + PS
194
©2013 MFMER | 3284068-194
195
©2013 MFMER | 3284068-195
196
©2013 MFMER | 3284068-196
197
©2013 MFMER | 3284068-197
Issues After Rastelli Repair
• 1964-2001
• 1,270 patients pulmonary ventricle pulmonary artery conduit
• 232 with TGA
• Freedom from reop worst in TGA
• TGA-PS-VSD: Shunt early
• Hold off on conduit until 2-3 years old
Dearani et al: Ann Thorac Surg, 2003
198
©2013 MFMER | 3284068-198
Surgical – Corrected TGA Summary
• Long-term outlook is good
• Atrial switch
• Long-term rhythm issues
• Surveillance for RV dysfunction, medical management?
• Arterial switch
• Progressive aortic regurgitation
• Rastelli
• RV PA conduit replacement
• Sub-AS surveillance
199
©2013 MFMER | 3284068-199
Thank you!
Website: www.cardiovascular.education-registration.com/selfstudy
Email: [email protected]
Phone: 507-266-6645